Simulations Plus, Inc. develops groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies around the world. Simulations Plus also provides consulting expertise to pharmaceutical and chemical companies worldwide. The company operates in North America, Europe, Asia and South America. For more information, visit the company’s website at www.simulations-plus.com.